| pubmed-article:11814811 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11814811 | lifeskim:mentions | umls-concept:C1142644 | lld:lifeskim |
| pubmed-article:11814811 | lifeskim:mentions | umls-concept:C0598941 | lld:lifeskim |
| pubmed-article:11814811 | lifeskim:mentions | umls-concept:C0220908 | lld:lifeskim |
| pubmed-article:11814811 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
| pubmed-article:11814811 | lifeskim:mentions | umls-concept:C1553497 | lld:lifeskim |
| pubmed-article:11814811 | lifeskim:mentions | umls-concept:C1705938 | lld:lifeskim |
| pubmed-article:11814811 | lifeskim:mentions | umls-concept:C1527178 | lld:lifeskim |
| pubmed-article:11814811 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11814811 | pubmed:dateCreated | 2002-3-7 | lld:pubmed |
| pubmed-article:11814811 | pubmed:abstractText | A virtual screening test to identify potential CP450 3A4 inhibitors has been developed. Molecular structures of inhibitors and non-inhibitors available in the Genetest database were represented using 2D Unity fingerprints and a feedforward neural network was trained to classify molecules regarding their inhibitory activity. Validation tests revealed that our neural net recognizes at least 89% of 3A4 inhibitors and suggest using this methodology in our virtual screening protocol. | lld:pubmed |
| pubmed-article:11814811 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11814811 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11814811 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11814811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11814811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11814811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11814811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11814811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11814811 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11814811 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:11814811 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:11814811 | pubmed:author | pubmed-author:MolnarLászlóL | lld:pubmed |
| pubmed-article:11814811 | pubmed:author | pubmed-author:KeseruGyörgy... | lld:pubmed |
| pubmed-article:11814811 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11814811 | pubmed:day | 11 | lld:pubmed |
| pubmed-article:11814811 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:11814811 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11814811 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11814811 | pubmed:pagination | 419-21 | lld:pubmed |
| pubmed-article:11814811 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:11814811 | pubmed:meshHeading | pubmed-meshheading:11814811... | lld:pubmed |
| pubmed-article:11814811 | pubmed:meshHeading | pubmed-meshheading:11814811... | lld:pubmed |
| pubmed-article:11814811 | pubmed:meshHeading | pubmed-meshheading:11814811... | lld:pubmed |
| pubmed-article:11814811 | pubmed:meshHeading | pubmed-meshheading:11814811... | lld:pubmed |
| pubmed-article:11814811 | pubmed:meshHeading | pubmed-meshheading:11814811... | lld:pubmed |
| pubmed-article:11814811 | pubmed:meshHeading | pubmed-meshheading:11814811... | lld:pubmed |
| pubmed-article:11814811 | pubmed:meshHeading | pubmed-meshheading:11814811... | lld:pubmed |
| pubmed-article:11814811 | pubmed:meshHeading | pubmed-meshheading:11814811... | lld:pubmed |
| pubmed-article:11814811 | pubmed:meshHeading | pubmed-meshheading:11814811... | lld:pubmed |
| pubmed-article:11814811 | pubmed:meshHeading | pubmed-meshheading:11814811... | lld:pubmed |
| pubmed-article:11814811 | pubmed:meshHeading | pubmed-meshheading:11814811... | lld:pubmed |
| pubmed-article:11814811 | pubmed:meshHeading | pubmed-meshheading:11814811... | lld:pubmed |
| pubmed-article:11814811 | pubmed:meshHeading | pubmed-meshheading:11814811... | lld:pubmed |
| pubmed-article:11814811 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11814811 | pubmed:articleTitle | A neural network based virtual screening of cytochrome P450 3A4 inhibitors. | lld:pubmed |
| pubmed-article:11814811 | pubmed:affiliation | Computer Assisted Drug Discovery, Gedeon Richter Ltd., PO Box 27, H-1475 Budapest, Hungary. | lld:pubmed |
| pubmed-article:11814811 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:11814811 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11814811 | lld:pubmed |
